Pediatric Hodgkin lymphoma: past, present and future-Reference-Cited by-同舟云学术

Pediatric Hodgkin lymphoma: past, present and future

Published:2009-12 Issue:6 Volume:3 Page:593-606
ISSN:1745-5111
Container-title:Pediatric Health
language:en
Short-container-title:Pediatric Health

Author:

Weiss Aaron¹,Neier Michelle¹,Drachtman Richard A¹

Affiliation:

1. The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine & Dentistry of New Jersey, NJ 08901, USA.

Abstract

The history of treatment of Hodgkin lymphoma in children and young adults has been one of increasing success, with the focus shifting in recent years from cure, regardless of the cost, to an increasing concern regarding late effects and other consequences of treatment. Ongoing protocols continue to explore the use of risk-based therapy, further delineating the ability to individualize therapy in an effort to decrease morbidity and mortality, while preserving excellent cure rates.

Publisher

Future Medicine Ltd

Subject

Pediatrics,Pediatrics, Perinatology and Child Health

Link

https://www.futuremedicine.com/doi/pdf/10.2217/phe.09.60

Reference91 articles.

1. Special issues in pediatric Hodgkin's disease

2. Treatment of Pediatric Hodgkin Lymphoma

3. RiesLAG, Eisner MP, Kosary CLet al.: SEER Cancer Statistics Review, 1975–2000. National Cancer Institute, Bethesda, MD, USA (2003).

4. O’LearyM, Sheaffer J, Keller F, Shu X: Lymphomas and reticuloendothelial neoplasms. In:Cancer Epidemiology in Older Adolescents and Young Adults Age 15–29 Years of Age, Including SEER Incidence and Survival: 1975–2000. Bleyer A, O’Leary M, Barr R, LAG R (Eds). National Cancer Institute, Bethesda, MD, USA (2006).

5. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence